-
Hawks guard Young poised to resume practice after knee sprain
-
Salah back in Liverpool fold as Arsenal grab last-gasp win
-
Raphinha extends Barca's Liga lead, Atletico bounce back
-
Glasgow comeback upends Toulouse on Dupont's first start since injury
-
Two own goals save Arsenal blushes against Wolves
-
Trump vows revenge after troops in Syria killed in alleged IS ambush
-
Maresca bemoans 'worst 48 hours at Chelsea' after lack of support
-
Teenage pair Ndjantou, Mbaye star as PSG beat Metz to go top
-
Drone strike in southern Sudan kills 6 UN peacekeepers
-
Crime wave propels hard-right candidate toward Chilean presidency
-
'Magic' Jalibert guides Bordeaux-Begles past Scarlets
-
Teenage pair Ndjantou and Mbaye star as PSG beat Metz to go top
-
Anglo-French star Jane Birkin gets name on bridge over Paris canal
-
Jalibert masterclass guides Bordeaux-Begles past Scarlets
-
M23 marches on in east DR Congo as US vows action against Rwanda
-
Raphinha double stretches Barca's Liga lead in Osasuna win
-
Terrific Terrier returns Leverkusen to fourth
-
Colts activate 44-year-old Rivers for NFL game at Seattle
-
US troops in Syria killed in IS ambush attack
-
Liverpool's Slot says 'no issue to resolve' with Salah after outburst
-
'Stop the slaughter': French farmers block roads over cow disease cull
-
Stormers see off La Rochelle, Sale stun Clermont in Champions Cup
-
Maresca hails Palmer as Chelsea return to winning ways against Everton
-
Hungarian protesters demand Orban quits over abuse cases
-
Belarus frees protest leader Kolesnikova, Nobel winner Bialiatski
-
Salah sets up goal on return to Liverpool action
-
Palmer strikes as Chelsea return to winning ways against Everton
-
Pogacar targets Tour de France Paris-Roubaix and Milan-San Remo in 2026
-
Salah back in action for Liverpool after outburst
-
Atletico recover Liga momentum with battling win over Valencia
-
Meillard leads 'perfect' Swiss sweep in Val d'Isere giant slalom
-
Salah on Liverpool bench for Brighton match
-
Meillard leads Swiss sweep in Val d'Isere giant slalom
-
Indonesia flood death toll passes 1,000 as authorities ramp up aid
-
First urban cable car unveiled outside Paris
-
Vonn second behind Aicher in World Cup downhill at St Moritz
-
Aicher pips Vonn to downhill win at St Moritz
-
Thailand says 4 soldiers killed in Cambodia conflict, denies Trump truce claim
-
Fans vandalise India stadium after Messi's abrupt exit
-
Women sommeliers are cracking male-dominated wine world open
-
Exhibition of Franco-Chinese print master Zao Wou-Ki opens in Hong Kong
-
Myanmar junta denies killing civilians in hospital strike
-
Why SpaceX IPO plan is generating so much buzz
-
Thailand continues Cambodia strikes despite Trump truce calls
-
US envoy to meet Zelensky, Europe leaders in Berlin this weekend
-
North Korea acknowledges its troops cleared mines for Russia
-
US unseals warrant for tanker seized off Venezuelan coast
-
Cambodia says Thailand still bombing hours after Trump truce call
-
Machado urges pressure so Maduro understands 'he has to go'
-
Leinster stutter before beating Leicester in Champions Cup
Ghostwriters, polo shirts, and the fall of a landmark pesticide study
A flagship study that declared the weedkiller Roundup posed no serious health risks has been retracted with little fanfare, ending a 25-year saga that exposed how corporate interests can distort scientific research and influence government decision-making.
Published in Regulatory Toxicology and Pharmacology in 2000, the paper ranks in the top 0.1 percent of citations among studies on glyphosate -- the key ingredient in Roundup, owned by agri-giant Monsanto and at the center of cancer lawsuits worth billions of dollars.
In his retraction note last week, the journal's editor-in-chief, Martin van den Berg, cited a litany of serious flaws from failing to include carcinogenicity studies available at the time to undisclosed contributions by Monsanto employees and even questions around financial compensation.
Elsevier, the journal's Dutch publisher, told AFP in a statement that it upholds the "highest standards of rigor and ethics" and that "as soon as the current editor became aware of concerns regarding this paper a matter of months ago, due process began."
But it did not address the fact that concerns date back to 2002, when critics wrote to Elsevier about "conflicts of interest, lack of transparency, and the absence of editorial independence" at the journal, including specific worries about Monsanto.
The matter exploded into public view in 2017, when internal corporate documents released during litigation showed one of Monsanto's own scientists admitting to "ghostwriting."
Harvard University science historian Naomi Oreskes, who co-authored a paper this September detailing the extent of the "fraud" in the 2000 study, told AFP that while she was "very gratified" at the "long overdue" action, but warned that "the scientific community needs better mechanisms to identify and retract fraudulent papers."
"This is completely in alignment with what we were calling them out for at the time," Lynn Goldman, a pediatrician and epidemiologist at GWU who co-signed the 2002 letter, added to AFP.
- Polo shirts -
Two of the paper's three original authors have since died, while first author Gary Williams, a professor at New York Medical College, did not respond to AFP's request for comment.
Monsanto maintains it acted appropriately, and that its product is safe. "Monsanto's involvement with the Williams et al paper did not rise to the level of authorship and was appropriately disclosed in the acknowledgments."
The company declined to comment on internal emails that suggested otherwise, including one in which a Monsanto scientist asked a colleague whether "the team of people" who worked on the Williams paper and another study "could receive Roundup polo shorts as a token of appreciation for a job well done."
Glyphosate was brought to market as a herbicide in the 1970s and initially welcomed as less toxic than DDT.
But its soaring use -- especially after Monsanto introduced glyphosate-tolerant seeds that allowed it to be sprayed widely over crops -- drew increasing scrutiny in the 1990s, making the 2000 paper hugely influential.
According to Oreskes's research, it was cited as supporting evidence for glyphosate's safety by groups ranging from the Canadian Forest Service to the International Court of Justice, the US Congress and the European Parliamentary Research Service.
- Legal interest -
In 2015, the World Health Organization's International Agency for Research on Cancer classified glyphosate as "probably carcinogenic to humans."
Several countries have since moved to restrict or ban its use, including France, which has prohibited household applications. Bayer, which acquired Monsanto, said it would phase out Roundup for US residential use in 2023 in response to growing lawsuits.
Nathan Donley, a scientist with the Center for Biological Diversity, told AFP he does not expect the retraction to sway the US Environmental Protection Agency, now under the pro-agricultural-industry Donald Trump administration, which has thrown its weight behind Bayer in an ongoing Supreme Court case.
But "it could play a role in litigation that is moving forward in the US against the EPA's proposed decision to renew glyphosate," Donley told AFP, adding that European regulators might also take note.
For Donley and others, the deeper concern is that the case may be far from unique.
"I am sure there (are a) lot (of) such ghost-written and undeclared conflict papers in the literature, but they are very difficult to unearth unless one goes really deep in litigation cases," John Ioannidis, a Stanford University professor who founded the field of meta-research told AFP.
M.Vogt--VB